Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Cynthia T . McMurray, Ph.D.

Back to Research Profile

  1. Liu Y, Prasad R, Beard WA, Hou EW, Horton JK, McMurray CT, Wilson SH. Coordination between polymerase beta and FEN1 can modulate CAG repeat expansion. J Biol Chem 2009 Oct 9; 284(41):28352-66.
    View PubMed
  2. Trushina E, Rana S, McMurray CT, Hua DH. Tricyclic pyrone compounds prevent aggregation and reverse cellular phenotypes caused by expression of mutant huntingtin protein in striatal neurons. BMC Neurosci 2009 Jul; 10.
    View PubMed
  3. Owen BA, H Lang W, McMurray CT. The nucleotide binding dynamics of human MSH2-MSH3 are lesion dependent. Nat Struct Mol Biol 2009 May; 16(5):550-7. Epub 2009 Apr 19.
    View PubMed
  4. Koti JS, Morais MC, Rajagopal R, Owen BAL, McMurray CT, Anderson DL. DNA packaging motor assembly intermediate of bacteriophage phi 29. J Mol Biol 2008 Sep 19; 381(5):1114-32.
    View PubMed
  5. Rolseth V, Runden-Pran E, Luna L, McMurray C, Bjoras M, Ottersen OP. Widespread distribution of DNA glycosylases removing oxidative DNA lesions in human and rodent brains. DNA Repair 2008 Sep 1; 7(9):1578-88.
    View PubMed
  6. McMurray CT. Hijacking of the mismatch repair system to cause CAG expansion and cell death in neurodegenerative disease. DNA Repair (Amst) 2008 Jul 1; 7(7):1121-34. Epub 2008 May 09.
    View PubMed
  7. Delagoutte E, Goellner GM, Guo J, Baldacci G, McMurray CT. Single-stranded DNA-binding protein in vitro eliminates the orientation-dependent impediment to polymerase passage on CAG/CTG repeats. J Biol Chem 2008 May 9; 283(19):13341-56. Epub 2008 Feb 08.
    View PubMed
  8. Kovtun IV, McMurray CT. Features of trinucleotide repeat instability in vivo. Cell Res 2008 Jan; 18(1):198-213.
    View PubMed
  9. Kovtun IV, Liu Y, Bjoras M, Klungland A, Wilson SH, McMurray CT. OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 2007 May 24; 447(7143):447-52. Epub 2007 Apr 22.
    View PubMed
  10. Trushina E, McMurray CT. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 2007 Apr 14; 145(4):1233-48.
    View PubMed
  11. Kovtun IV, McMurray CT. Crosstalk of DNA glycosylases with pathways other than base excision repair. DNA Repair (Amst) 2007 Apr 1; 6(4):517-29.
    View PubMed
  12. Trushina E, Singh RD, Dyer RB, Cao S, Shah VH, Parton RG, Pagano RE, McMurray CT. Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo. Hum Mol Genet 2006 Dec 15; 15(24):3578-91.
    View PubMed
  13. Trushina E, Du Charme J, Parisi J, McMurray CT. Neurological abnormalities in caveolin-1 knock out mice. Behav Brain Res 2006 Sep 15; 172(1):24-32. Epub 2006 Jun 05.
    View PubMed
  14. McMurray CT. To die or not to die: DNA repair in neurons. Mutat Res 2005 Sep 4; 577(1-2):260-74.
    View PubMed
  15. Owen BAL, Yang ZY, Lai MY, Gajek M, Badger JD, Hayes JJ, Edelmann W, Kucherlapati R, Wilson TM, McMurray CT. (CAG)(n)-hairpin DNA binds to Msh2-Msh3 and changes properties of mismatch recognition. Nat Struct Mol Biol 2005 Aug; 12(8):663-70.
    View PubMed
  16. Kantarci OH, Goris A, Hebrink DD, Heggarty S, Cunningham S, Alloza I, Atkinson EJ, de Andrade M, McMurray CT, Graham CA, Hawkins SA, Billiau A, Dubois B, Weinshenker BG, Vandenbroeck K. IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis. Genes Immun 2005 Mar; 6(2):153-61.
    View PubMed
  17. Ortiz M, Sanoguel Z, Hu HT, Chazin WJ, McMurray C, Salisbury JL, Pastrana-Rios B. Dynamics of hydrogen - Deuterium exchange in Chlamydomonas centrin. Biochemistry 2005 Feb 22; 44(7):2409-18.
    View PubMed
  18. Eide L, McMurray CT. Culture of adult mouse neurons. Biotechniques 2005 Jan; 38(1):99-104.
    View PubMed
  19. Trushina E, Dyer RB, Badger JD 2nd, Ure D, Eide L, Tran DD, Vrieze BT, Legendre-Guillemin V, McPherson PS, Mandavilli BS, Van Houten B, Zeitlin S, McNiven M, Aebersold R, Hayden M, Parisi JE, Seeberg E, Dragatsis I, Doyle K, Bender A, Chacko C, McMurray Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Molecular & Cellular Biology 2004 Sep; 24(18):8195-209.
    View PubMed
  20. Kantarci OH, Hebrink DD, Achenbach SJ, Pittock SJ, Altintas A, Schaefer-Klein JL, Atkinson EJ, de Andrade M, McMurray CT, Rodriguez M, Weinshenker BG. Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology 2004 Mar 9; 62(5):811-4.
    View PubMed
  21. Kovtun IV, Welch G, Guthrie HD, Hafner KL, McMurray CT. CAG repeat lengths in X- and Y-bearing sperm indicate that gender bias during transmission of Huntington's disease gene is determined in the embryo. J Biol Chem 2004 Mar 5; 279(10):9389-91.
    View PubMed
  22. Kantarci OH, Hebrink DD, Achenbach SJ, Atkinson EJ, de Andrade M, McMurray CT, Weinshenker BG. CD95 polymorphisms are associated with susceptibility to MS in women - A population-based study of CD95 and CD95L in MS. J Neuroimmunol 2004 Jan; 146(1-2):162-70.
    View PubMed
  23. Trushina E, Heldebrant MP, Perez-Terzic CM, Bortolon R, Kovtun IV, Badger JD, Terzic A, Estevez A, Windebank AJ, Dyer RB, Yao J, McMurray CT. Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease. Proc Natl Acad Sci U S A 2003 Oct 14; 100(21):12171-6.
    View PubMed
  24. Spiro C, McMurray CT. Nuclease-deficient FEN-1 blocks rad51/BRCA1-mediated repair and causes trinucleotide repeat instability. Mol Cell Biol 2003 Sep; 23(17):6063-74.
    View PubMed
  25. Morais MC, Kanamaru S, Badasso MO, Koti JS, Owen BAL, McMurray CT, Anderson DL, Rossmann MG. Bacteriophage phi 29 scaffolding protein gp7 before and after prohead assembly. Nat Struct Biol 2003 Jul; 10(7):572-6.
    View PubMed
  26. McMurray CT, Kortun IV. Repair in haploid male germ cells occurs late in differentiation as chromatin is condensing. Chromosoma 2003 May; 111(8):505-8.
    View PubMed
  27. Kantarci OH, Schaefer-Klein JL, Hebrink DD, Achenbach SJ, Atkinson EJ, McMurray CT, Weinshenker BG. A population-based study of IL4 polymorphisms in multiple sclerosis. J Neuroimmunol 2003 Apr; 137(1-2):134-9.
    View PubMed
  28. Johnson-Pais TL, Singer FR, Bone HG, McMurray CT, Hansen MF, Leach RJ. Identification of a novel tandem duplication in Exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis. J Bone Miner Res 2003 Feb; 18(2):376-80.
    View PubMed
  29. Kantarci OH, Hebrink DD, Achenbach SJ, Atkinson EJ, Waliszewska A, Buckle G, McMurray CT, de Andrade M, Hafler DA, Weinshenker BG. CTLA4 is associated with susceptibility to multiple sclerosis. J Neuroimmunol 2003 Jan; 134(1-2):133-41.
    View PubMed
  30. Sobell JL, Mikesell MJ, McMurray CT. Genetics and etiopathophysiology of schizophrenia. Mayo Clin Proc 2002 Oct; 77(10):1068-82.
    View PubMed
  31. Hopfner KP, Craig L, Moncalian G, Zinkel RA, Usui T, Owen BA, Karcher A, Henderson B, Bodmer JL, McMurray CT, Carney JP, Petrini JHJ, Tainer JA. The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination and repair. Nature 2002 Aug 1; 418(6897):562-6.
    View PubMed
  32. Kantarci OH, Lesnick TG, Yang P, Meyer RL, Hebrink DD, McMurray CT, Weinshenker BG. Myeloperoxidase-463 (G -> A) polymorphism associated with lower risk of lung cancer. Mayo Clin Proc 2002 Jan; 77(1):17-22.
    View PubMed
  33. Pastrana-Rios B, Ocana W, Rios M, Vargas GL, Isa G, Pointer G, Hildebrand MP, McMurray CT, Salisbury JL. PCentrin: Its Secondary Structure in the Presence and Absence of Cations. Biochemistry 2002; 41(22):6911-9.
    View PubMed
  34. McMurray CT. Huntington's disease. Expanding horizons for treatment. Lancet 2001 Dec; 358(Suppl):S37.
    View PubMed
  35. McMurray CT. Expanding horizons for treatment. Lancet 2001 Dec; (Suppl S):S37.
  36. McMurray SE, McMurray CT. A sports star and a cook. Lancet 2001 Dec; (Suppl S):S38.
  37. Weinshenker BG, Hebrink D, Kantarci OH, Schaefer-Klein J, Atkinson E, Schaid D, McMurray CM. Genetic variation in the transforming growth factor beta 1 gene in multiple sclerosis. J Neuroimmunol 2001 Nov 1; 120(1-2):138-45.
    View PubMed
  38. McMurray CT. Huntington's disease: new hope for therapeutics. Trends Neurosci 2001 Nov; 24(11 Suppl S):S32-8.
    View PubMed
  39. Dyer RB, McMurray CT. Mutant protein in Huntington disease is resistant to proteolysis in affected brain. Nat Genet 2001 Nov; 29(3):270-278.
    View PubMed
  40. Kovtun IV, Goellner G, McMurray CT. Structural features of trinucleotide repeats associated with DNA expansion. Biochem Cell Biol 2001 Jun; 79(3):325-36.
    View PubMed
  41. Kovtun IV, McMurray CT. Trinucleotide expansion in haploid germ cells by gap repair. Nat Genet 2001 Apr; 27(4):407-11.
    View PubMed
  42. Wu X, McMurray CT. Calmodulin kinase II attenuation of gene transcription by preventing cAMP response element-binding protein (CREB) dimerization and binding of the CREB-binding protein. J Biol Chem 2001 Jan 19; 276(3):1735-41.
    View PubMed
  43. Kovtun IV, Therneau TM, McMurray CT. Gender of the embryo contributes to CAG instability in transgenic mice containing a Huntington's disease gene. Hum Mol Genet 2000 Nov 1; 9(18):2767-75.
    View PubMed
  44. Raca G, Siyanova EY, McMurray CT, Mirkin SM. Expansion of the (CTG)(n) repeat in the 5'-UTR of a reporter gene impedes translation. Nucleic Acids Res 2000 Oct 15; 28(20):3943-9.
    View PubMed
  45. McMurray CT. Neurodegeneration: diseases of the cytoskeleton? Cell Death & Differentiation 2000 Oct; 7(10):861-5.
    View PubMed
  46. Kantarci OH, Atkinson EJ, Hebrink DD, McMurray CT, Weinshenker BG. Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis. J Neuroimmunol 2000 Jul 1; 106(1-2):220-7.
    View PubMed
  47. Weinshenker BG, Hebrink DD, Klein C, Atkinson EJ, O'Brien PC, McMurray CT. Genetic variation in the B7-1 gene in patients with multiple sclerosis. J Neuroimmunol 2000 Jun 26; 105(2):184-8.
    View PubMed
  48. Kantarci OH, Atkinson EJ, Hebrink DD, McMurray CT, Weinshenker BG. Association of a myeloperoxidase promoter polymorphism with multiple sclerosis. J Neuroimmunol 2000 Jun 26; 105(2):189-94.
    View PubMed
  49. Richard GF, Goellner GM, McMurray CT, Haber JE. Recombination-induced CAG trinucleotide repeat expansions in yeast involve the MRE11-RAD50-XRS2 complex. EMBO J 2000 May 15; 19(10):2381-90.
    View PubMed
  50. Hoyne PR, Gacy AM, McMurray CT, Maher LJ 3rd. Stabilities of intrastrand pyrimidine motif DNA and RNA triple helices. Nucleic Acids Res 2000 Feb 1; 28(3):770-5.
    View PubMed
  51. Kantarci OH, Atkinson EJ, Hebrink DD, McMurray CT, Weinshenker BG. A population-based association study of two polymorphisms in the IL-1 beta and IL-1 receptor antagonist genes with susceptibility to and severity of multiple sclerosis. J Neuroimmunol 2000; 106:220-7.
    View PubMed
  52. Trushina YV, McMurray CT. Measurement of nitrosothiols in biological samples for automated analysis. Recent Research Developments in Analytical Chemistry 2000; 1:1-20.
  53. Trushina EV, Oda RP, McMurray CT, Landers JP. Effective and reproducible capillary electrophoretic separation of thiols under conditions where exceptionally high current is generated. Anal Chem 1999 Dec 15; 71(24):5569-73.
    View PubMed
  54. Spiro C, Pelletier R, Rolfsmeier ML, Dixon MJ, Lahue RS, Gupta G, Park MS, Chen X, Mariappan SV, McMurray CT. Inhibition of FEN-1 processing by DNA secondary structure at trinucleotide repeats. Mol Cell 1999 Dec; 4(6):1079-85.
    View PubMed
  55. Hopkins HP, Hamilton DD, Wilson WD, McMurray CT. Calorimetric studies on the pH dependence in hairpin formation within the human enkephalin enhancer region. J Solution Chem 1999 Jun; 28(6):759-768.
  56. Weinshenker BG, Hebrink D, Wingerchuk DM, Klein CJ, Atkinson E, O'Brien PC, McMurray CT. Genetic variants in the tumor necrosis factor receptor 1 gene in patients with MS. Neurology 1999 Apr 22; 52(7):1500-3.
    View PubMed
  57. McMurray CT. DNA secondary structure: a common and causative factor for expansion in human disease. Proc Natl Acad Sci U S A 1999 Mar 2; 96(5):1823-5.
    View PubMed
  58. Weinshenker B, Hebrink D, Wingerchuk DM, Klein CJ, Atkinson E, O'Brien PC, McMurray CT. A comprehensive study of genetic variants in the tumor necrosis factor receptor 1 (TNFR1) gene in patients with multiple sclerosis. Neurology 1999; 52:1500-03.
    View PubMed
  59. Wu X, Spiro C, Owen WG, McMurray CT. cAMP response element-binding protein monomers cooperatively assemble to form dimers on DNA. J Biol Chem 1998 Aug 14; 273(33):20820-7.
    View PubMed
  60. Spiro C, McMurray CT. Regulation of the proenkephalin enhancer and synthesis by conformational switching: implications for decoy design. Antisense & Nucleic Acid Drug Development 1998 8:159-165.
  61. Weinshenker BG, Hebrink DD, Gacy AM, McMurray CT. DNA compression caused by an upstream point mutation. Biotechniques 1998 Jul; 25(1):68-72.
    View PubMed
  62. Zhang F, Lemieux S, Wu X, St-Arnaud D, McMurray CT, Major F, Anderson D. Function of hexameric RNA in packaging of bacteriophage phi 29 DNA in vitro. Mol Cell 1998 Jul; 2(1):141-7.
    View PubMed
  63. Gacy AM, McMurray CT. Influence of hairpins on template reannealing at trinucleotide repeat duplexes: a model for slipped DNA. Biochemistry 1998 Jun 30; 37(26):9426-34.
    View PubMed
  64. Spiro C, McMurray CT. Transcriptional regulation of the human proenkephalin gene by conformational switching: implications for decoy design. Antisense & Nucleic Acid Drug Development 1998 Apr; 8(2):159-65.
    View PubMed
  65. Gacy AM, Goellner GM, Spiro C, Chen X, Gupta G, Bradbury EM, Dyer RB, Mikesell MJ, Yao JZ, Johnson AJ, Richter A, Melancon SB, McMurray CT. GAA instability in Friedreich's Ataxia shares a common, DNA-directed and intraallelic mechanism with other trinucleotide diseases. Mol Cell 1998 Mar; 1(4):583-93.
    View PubMed
  66. McMurray CT. Commentary on Function of Hexameric RNA in Packaging of Bacteriophage p29 DNA in Vitro. Biochemistry and Molecular Biology (Special Issue "Biological Application of the Analytical Ultracentrifuge" Chemtracts) 1998; 11(13):994-9.
  67. Zhang F, Lemieux S, Wu X, McMurray CT, Major F, Anderson D, McMurray CT. Function of hexameric RNA in packaging of bacteriophage PHI29 DNA in vitro. Chemtracts 1998; 11(13):994-999.
  68. Spiro C, McMurray CT. Switching of DNA secondary structure in proenkephalin transcriptional regulation. J Biol Chem 1997 Dec 26; 272(52):33145-52.
    View PubMed
  69. Trushina EV, Oda RP, Landers JP, McMurray CT. Determination of nitrite and nitrate reduction by capillary ion electrophoresis. Electrophoresis 1997 Sep; 18(10):1890-8.
    View PubMed
  70. Mikesell MJ, Barron YD, Nimgaonkar VL, Sobell JL, Sommer SS, Mcmurray CT. Gly(247)-->Asp proenkephalin a mutation is rare in schizophrenia populations. Am J Med Genet 1997 Apr 18; 74(2):213-215.
    View PubMed
  71. Goellner GM, Tester D, Thibodeau S, Almqvist E, Goldberg YP, Hayden MR, McMurray CT. Different mechanisms underlie DNA instability in Huntington disease and colorectal cancer. Am J Hum Genet 1997 Apr; 60(4):879-90.
    View PubMed
  72. Weinshenker BG, Hebrink D, Wingerchuk DM, Sommer SS, McMurray CT. Application of VAPSE-based analysis to genetic studies in MS. Mult Scler 1997; 3:322.
  73. Mikesell MJ, Sobell JL, Sommer SS, McMurray CT. Identification of a missense mutation and several polymorphisms in the proenkephalin A gene of schizophrenic patients. Am J Med Genet 1996 Sep 20; 67(5):459-67.
    View PubMed
  74. Spiro C, Bazett-Jones DP, Wu X, McMurray CT. DNA structure determines protein binding and transcriptional efficiency of the proenkephalin cAMP-responsive enhancer. J Biol Chem 1995 Nov 17; 270(46):27702-10.
    View PubMed
  75. McMurray CT. Mechanisms of DNA expansion. Chromosoma 1995 Oct; 104(1):2-13.
    View PubMed
  76. Goldberg YP, McMurray CT, Zeisler J, Almqvist E, Sillence D, Richards F, Gacy AM, Buchanan J, Telenius H, Hayden MR. Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population. Hum Mol Genet 1995 Oct; 4(10):1911-8.
    View PubMed
  77. Gacy AM, Goellner G, Juranic N, Macura S, McMurray CT. Trinucleotide repeats that expand in human disease form hairpin structures in vitro. Cell 1995 May 19; 81(4):533-40.
    View PubMed
  78. Gacy AM, McMurray CT. Hairpin formation within the human enkephalin enhancer region. 1. Kinetic analysis. Biochemistry 1994 Oct 4; 33(39):11951-9.
    View PubMed
  79. McMurray CT, Juranic N, Chandrasekaran S, Macura S, Li Y, Jones RL, Wilson WD. Hairpin formation within the human enkephalin enhancer region. 2. Structural studies. Biochemistry 1994 Oct 4; 33(39):11960-70.
    View PubMed
  80. Collinshicok J, Lin L, Spiro C, Laybourn PJ, Tschumper R, Rapacz B, McMurray CT. Induction of the rat prodynorphin gene through GS-coupled receptors may involve phosphorylation-dependent depression and activation. Mol Cell Biol 1994 May; 14:2837-2848.
    View PubMed
  81. Spiro C, Richards JP, Chandrasekaran S, Brennan RG, McMurray CT. Secondary structure creates mismatched base pairs required for high-affinity binding of cAMP response element-binding protein to the human enkephalin enhancer. Proc Natl Acad Sci U S A 1993 May 15; 90(10):4606-10.
    View PubMed
  82. Kaynard AH, McMurray CT, Douglass J, Curry TE, Melner MH. Regulation of prodynorphin gene expression in the ovary: distal DNA regulatory elements confer gonadotropin regulation of promoter activity. Mol Endocrinol 1992 Dec; 6(12):2244-56.
    View PubMed
  83. McMurray CT, Pollock KM, Douglass J. Cellular and molecular analysis of opioid peptide gene expression. NIDA Res Monogr 1992; 126:113-31.
    View PubMed
  84. McMurray CT, Small EW, van Holde KE. Binding of ethidium to the nucleosome core particle. 2. Internal and external binding modes. Biochemistry 1991 Jun 11; 30(23):5644-52.
    View PubMed
  85. McMurray CT, van Holde KE. Binding of ethidium to the nucleosome core particle. 1. Binding and dissociation reactions. Biochemistry 1991 Jun 11; 30(23):5631-43.
    View PubMed
  86. McMurray CT, Wilson WD, Douglass JO. Hairpin formation within the enhancer region of the human enkephalin gene. Proc Natl Acad Sci U S A 1991 Jan 15; 88(2):666-70.
    View PubMed
  87. Kaynard AH, McMurray CT, Douglass JO, Melner MH. FSH and LH stimulation of granulosa cell prodynorphin gene expression is abolished by oversuppression of a non-functional mutant of the RII subunit of protein kinase A in regulation and actions of follicle stimulating hormone. Proceedings of the Serono Symposia 1991; 309-14.
  88. Douglass JO, Iadarola MJ, Hong JS, Garrett JE, McMurray CT. Transcriptional regulation of the rat prodynorphin gene. NIDA Res Monogr 1991; 111:133-48.
    View PubMed
  89. Yager TD, McMurray CT, van Holde KE. Salt-Induced Release of DNA from Nucleosome Core Particles. Biochemistry 1989; 28:2271-81.
    View PubMed
  90. Douglass JD, McMurray CT, Garrett J, Adelman JP, Calavetta L. Molecular characterization of the rat prodynorphin gene. Molecular Endocrinology 1989; 3(12):2070-8.
    View PubMed
  91. McMurray CT, Devi L, Calavetta L, Douglass JD. Regulated expression of prodynorphin gene in R2C Leydig tumor cells. Endocrinology 1988; 124(1):49-59.
  92. McMurray CT, Van Holde KE. Binding of Ethidium Bromide to Nucleosome Core Particles Causes Dissociation. Proc Natl Acad Sci 1986; 83:8472-6.
    View PubMed
  93. McMurray CT, van Holde KE, Jones RL, Wilson WD. 1H-NMR Studies of the Nucleosome Core Particle: Evidence for Regions of Altered Hydrogen Bonding. Proc Nat Acad Sci 1985; 24(25):7037-44.
  94. Marzilli LG, Reily MD, Heyl BL, McMurray CT, Wilson WD. Evidence for Similar Structural Changes on Binding of Platinum Anti-Tumor Agents to DNA and Nucleosomes. FEBS Lett 1984; 176(2):389-92.
    View PubMed


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.